Cargando…
Enhanced immunotherapy by combining a vaccine with a novel murine GITR ligand fusion protein
Immunotherapy was significantly enhanced in a murine tumor model by combining a vaccine with a fusion protein designed to target the glucocorticoid-induced tumor necrosis factor (TNF) receptor related gene (GITR) on the surface of T cells. The recombinant poxvirus-based vaccine platform included Mod...
Autores principales: | Morillon, Y. Maurice, Hammond, Scott A., Durham, Nicholas M., Schlom, Jeffrey, Greiner, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650275/ https://www.ncbi.nlm.nih.gov/pubmed/29088720 http://dx.doi.org/10.18632/oncotarget.20703 |
Ejemplares similares
-
Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody
por: Fallon, Jonathan K., et al.
Publicado: (2017) -
GITR ligand fusion protein agonist enhances the tumor antigen–specific CD8 T-cell response and leads to long-lasting memory
por: Durham, Nick M., et al.
Publicado: (2017) -
Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
por: Amoozgar, Zohreh, et al.
Publicado: (2021) -
Combination therapy with an OX40L fusion protein and a vaccine targeting the transcription factor twist inhibits metastasis in a murine model of breast cancer
por: Malamas, Anthony S., et al.
Publicado: (2017) -
NHS-IL12, a Tumor-Targeting Immunocytokine
por: Greiner, John W, et al.
Publicado: (2021)